A second human case of H5N1 virus infection has been identified in the state of Michigan, according to the Centers for Disease Control and Prevention (CDC).
This is the third human case associated with an ongoing multistate outbreak of H5N1 in U.S. dairy cows. None of the three cases are associated with the others. As with the previous two cases (one in Texas, one in Michigan), the person is a dairy farm worker with exposure to infected cows, making this another instance of probable cow-to-person spread.
This is the first human case of H5N1 in the United States to report more typical symptoms of acute respiratory illness associated with influenza virus infection, including H5N1 viruses. CDC continues to closely monitor available data from influenza surveillance systems , particularly in affected states, and there has been no sign of unusual influenza activity in people, including no increase in emergency room visits for influenza and no increase in laboratory detection of human influenza cases.
Based on the information available at this time, this case does not change CDC’s current H5N1 bird flu human health risk assessment for the U.S. general public because all three sporadic cases had direct contact with infected cows. Risk depends on exposure, and in this case, the relevant exposure is to infected animals. The risk to members of the general public who do not have exposure to infected animals remains low. However, this development underscores the importance of recommended precautions in people with exposure to infected or potentially infected animals. People with close or prolonged, unprotected exposures to infected birds or other animals (including livestock), or to environments contaminated by infected birds or other infected animals, are at greater risk of infection and should take precautions.
Case background
A dairy worker with exposure to H5N1-infected cows (at a different farm from the case the previous week) reported symptoms to local health officials. The patient reported upper respiratory tract symptoms including cough without fever, and eye discomfort with watery discharge. The patient was given antiviral treatment with oseltamivir, is isolating at home, and their symptoms are resolving. Household contacts of the patient have not developed symptoms, are being monitored for illness, and have been offered oseltamivir. No other workers at the same farm have reported symptoms, and all staff are being monitored. There is no indication of person-to-person spread of A(H5N1) viruses at this time.
